UNIVERSITY OF CALIFORNIA, SAN DIEGO
...UEIUYTTZT6G9DT1·Profile updated 2026-05-13
Awards tracked
5
Total amount
$246.9M
Date range
—
Primary sector
—
Volume
—
$/month, last 24
About this recipient
UNIVERSITY OF CALIFORNIA, SAN DIEGO has received $246.9M in tracked federal funding across the ingest window.
The largest single source of funding is Department of Health and Human Services, which dominates the recipient's federal portfolio. We surface the full breakdown of contracts and grants below.
A longer, LLM-generated profile becomes available for the top entities by total $ awarded. We do not take editorial direction from recipients.
Portfolio by sector
Sectors classified by LLM on each award.
- unclassified5 awards$246.9M 100%
Portfolio status
Based on each award's period of performance.
Active
4
active80% of awards
Expiring (≤90d)
1
expiring · 30d20% of awards
Expired
0
expired0% of awards
No POP
0
—0% of awards
Top awarding agencies
Department of Health and Human Services
$209.2M 85%
National Science Foundation
$37.8M 15%
Based on 5 awards totaling $246,938,798.
Awards
Top 5 by amount
| Action date | Recipient | Agency | Amount | Description | Sector | Status |
|---|---|---|---|---|---|---|
| — | UNIVERSITY OF CALIFORNIA, SAN DIEGO | Department of Health and Human Services | $87,950,497 | SPECIALIZED CANCER CENTER SUPPORT GRANT | — | active |
| — | UNIVERSITY OF CALIFORNIA, SAN DIEGO | Department of Health and Human Services | $50,238,889 | UCSD DEPARTMENT OF MEDICINE HIV/AIDS CLINICAL TRIALS UNIT | — | active |
| — | UNIVERSITY OF CALIFORNIA, SAN DIEGO | National Science Foundation | $37,758,328 | CATEGORY I. COMPUTING WITHOUT BOUNDARIES: CYBERINFRASTRUCTURE FOR THE LONG TAIL OF SCIENCE | ai-infrastructure | active |
| — | UNIVERSITY OF CALIFORNIA, SAN DIEGO | Department of Health and Human Services | $37,142,240 | THE HEALTHY BRAIN AND CHILD DEVELOPMENT NATIONAL CONSORTIUM ADMINISTRATIVE CORE - PROJECT SUMMARY NEURODEVELOPMENTAL PROCESSES ARE SHAPED BY DYNAMIC INTERACTIONS BETWEEN GENES AND ENVIRONMENTS. MALADAPTIVE EXPERIENCES EARLY IN LIFE CAN ALTER DEVELOPMENTAL TRAJECTORIES, LEADING TO HARMFUL AND ENDURING DEVELOPMENTAL SEQUELAE. PRE- AND POSTNATAL HAZARDS INCLUDE MATERNAL SUBSTANCE EXPOSURE, TOXICANT EXPOSURES IN PREGNANCY AND EARLY LIFE, MATERNAL HEALTH CONDITIONS, PARENTAL PSYCHOPATHOLOGY, MALTREATMENT, STRUCTURAL RACISM, AND EXCESSIVE STRESS. TO ELUCIDATE HOW VARIOUS ENVIRONMENTAL HAZARDS IMPACT CHILD DEVELOPMENT, IT IS IMPERATIVE THAT A NORMATIVE TEMPLATE OF DEVELOPMENTAL TRAJECTORIES OVER THE FIRST 10 YEARS OF LIFE BE ESTABLISHED BASED ON A SUFFICIENTLY LARGE AND DEMOGRAPHICALLY DIVERSE SAMPLE OF THE US POPULATION. TO ACCOMPLISH THIS, THE HEALTHY BRAIN AND CHILD DEVELOPMENT NATIONAL CONSORTIUM STUDY (HBCD) UNDER THE LEADERSHIP AND MANAGEMENT OF THE HBCD NATIONAL CONSORTIUM ADMINISTRATIVE CORE (HCAC) WILL DEPLOY A HARMONIZED, OPTIMIZED, AND INNOVATIVE SET OF NEUROIMAGING (MRI, EEG) MEASURES COMPLEMENTED BY AN EXTENSIVE BATTERY OF BEHAVIORAL, PHYSIOLOGICAL, AND PSYCHOLOGICAL TOOLS, AND BIOSPECIMENS TO UNDERSTAND NEURODEVELOPMENTAL TRAJECTORIES IN A SAMPLE OF 7,500 MOTHERS AND INFANTS ENROLLED AT SITES ACROSS THE US. THE OVERARCHING GOAL OF THE HBCD IS TO CREATE A COMPREHENSIVE, HARMONIZED, AND HIGH-DIMENSIONAL DATASET THAT WILL CHARACTERIZE TYPICAL NEURODEVELOPMENTAL TRAJECTORIES IN US CHILDREN AND THAT WILL ASSESS HOW BIOLOGICAL AND ENVIRONMENTAL EXPOSURES AFFECT THOSE TRAJECTORIES. A SPECIAL EMPHASIS WILL BE PLACED ON UNDERSTANDING THE IMPACT OF PRE- AND POSTNATAL EXPOSURE TO OPIOIDS, MARIJUANA, ALCOHOL, TOBACCO AND/OR OTHER SUBSTANCES. TO ADDRESS THESE BROAD OBJECTIVES, THE HCAC WILL OVERSEE STUDY DESIGN, DEVELOPMENT OF THE COMMON PROTOCOL, AND MONITOR RECRUITMENT AND RETENTION TO ENSURE THAT THE SAMPLE OF WOMEN ENROLLED INCLUDES: 1) A RACIALLY, ETHNICALLY, AND SOCIOECONOMICALLY DIVERSE COHORT THAT IS REPRESENTATIVE OF THE US POPULATION; 2) PREGNANT WOMAN WITH USE OF TARGETED SUBSTANCES (OPIOIDS, MARIJUANA, ALCOHOL, TOBACCO); AND 3) DEMOGRAPHICALLY AND BEHAVIORALLY SIMILAR WOMEN WITHOUT SUBSTANCE USE IN PREGNANCY TO ENABLE VALID CAUSAL INFERENCES. THE HCAC WILL ENSURE STUDY OBJECTIVES ARE MET, MONITOR PERFORMANCE, PROVIDE FOR TRAINING, ESTABLISH AND CARRY OUT DECISION-MAKING AND ETHICAL POLICIES, MANAGE ALL STUDY COMMUNICATIONS, AND OVERSEE PROCESSES FOR CONSIDERING STUDY MODIFICATIONS. IN COLLABORATION WITH THE HBCD NATIONAL CONSORTIUM DATA COORDINATING CENTER (HDCC), THE HCAC WILL ENSURE THAT APPROXIMATELY ANNUAL STUDY DATASETS ARE RELEASED TO THE BROADER SCIENTIFIC COMMUNITY. THE HBCD NATIONAL CONSORTIUM STUDY WILL INFORM PUBLIC POLICY TO IMPROVE THE HEALTH AND DEVELOPMENT OF CHILDREN ACROSS THE NATION. | biotech | expiring · 47d |
| — | UNIVERSITY OF CALIFORNIA, SAN DIEGO | Department of Health and Human Services | $33,848,843 | UNIVERSITY OF CALIFORNIA, SAN DIEGO CLINICAL TRIAL UNIT | biotech | active |
Sources
USAspending.gov — all awards for this UEI →SAM.gov entity registration →
Profile compiled from publicly available USAspending.gov records, ingested and entity-resolved by The Buildout's pipeline.